6
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Fecal Excretion of Radiolabeled (51CrCl3) Proteins in Patients with Crohn's Disease

, , , , &
Pages 345-351 | Received 06 Apr 1989, Accepted 25 Sep 1989, Published online: 08 Jul 2009

References

  • Filipsson S, Hultén L, Lindstedt G. Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease. Scand J Gastroenterol 1978; 13: 529–536
  • Hildell J, Lindstrom C, Wenckert A. Radiographic appearances in Crohn's disease. Acta Radiol Diagn 1979; 20: 609–625
  • Garlock J, Crohn B. An appraisal of the results of surgery in the treatment of regional ileitis. JAMA 1945; 127: 205
  • Dyson W L, Hodes P J. Rhoads JE. Late results in the surgical treatment of regional enteritis. Pa Med 1954; 57: 433–438
  • Davis J. The prognosis of Crohn's disease. Postgrad Med J 1961; 37: 783
  • Schölmerich J, Schmidt E, Schümichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Gastroenterology 1988; 95: 1287–93
  • Bjarnason I, Zanelli G, Smith T. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480–89
  • Steinfeld J, Davidson J, Gordon R, Greene F. The mechanism of hypoproteinemia in patients with regional enteritis and ulcerative colitis. Am J Med 1960; 29: 405–415
  • Jarnum S, Jensen K B. Fecal radioiodine excretion following intravenous injection of 131I-albumin and 125I-immunoglobulin G in chronic inflammatory bowel disease. Gastroenterology 1975; 68: 1433–1444
  • Beeken W L, Busch H J, Sylwester D L. Intestinal protein loss in Crohn's disease. Gastroenterology 1972; 62: 207–215
  • Fasth S, Hellberg R, Hultén L, Magnusson O. Early complications after surgical treatment for Crohn's disease with particular reference to factors affecting their development. Acta Chir Scand 1980; 146: 519–526
  • Morson B C. Crohn's disease. Proc Roy Soc Med 1968; 61: 79–81
  • Rootwelt K. Direct intravenous injection of 51chromic chloride compared with l25I-polyvinyl-pyrrolidone and 131I-albumin in the detection of gastrointestinal protein loss. Scand J Clin Lab Invest 1966; 18: 405–416
  • Sköldborn H., Arvidsson B, Andersson M. A new whole body monitoring laboratory. Acta Radiol 1972; 233–241, suppl 313
  • Walker-Smith J A, Skyring A P, Mistilis S P. Use of 51CrCl3 in the diagnosis of protein-losing enteropathy. Gut 1967; 8: 166–168
  • Jarnum S, Westergaard H, Yssing M, Jensen H. Quantitation of gastrointestinal protein loss by means of Fe59-labeled iron dextran. Gastroenterology 1968; 55: 229–241
  • Eustace P W, Gaunt J I. Croft DN. Incidence of protein-losing enteropathy in primary lympho-edema using chromium-51 chloride technique. Br Med J 1975; 4: 737
  • Kinmonth J B, Eustace P W. Gut protein loss in lymphoedema. Proc Roy Soc Med 1975; 68: 673–675
  • Da Costa L R, Croft D N, Creamer B. Protein loss and cell loss from the small-intestinal mucosa. Gut 1971; 12: 179–183
  • Gordon R, Jr. Exudative enteropathy: Abnormal permeability of the gastrointestinal tract demonstrable with labelled polyvinyl pyrrolidone. Lancet 1959; 1: 325
  • Jarnum S. The 131-polyvinylpyrrolidone (131I-PVP) test in gastrointestinal protein loss. Scand J Clin Lab Invest 1961; 13: 447–461
  • Waldmann T A. Gastrointestinal protein loss demonstrated by 51Cr-labelled albumin. Lancet 1961; 2: 121–123
  • Waldmann T A. Protein-losing enteropathy and kinetic studies of plasma protein metabolism. Semin Nucl Med 1972; 2: 251–264
  • Karbach U, Ewe K, Dehos K. Antiinflammatory treatment and intestinal cr-1-antitrypsin clearance in active Crohn's disease. Dig Dis Sci 1985; 30: 229–235
  • Van Tongeren J H, Eekhout A L. Criteria to assess the severity of Crohn's disease and the effect of treatment. The management of Crohn's disease, I T. Weterman, A S. Peña, C C. Booth. Exerpta Medica, Amsterdam 1976; 153–160

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.